The Century Therapeutics team spends the day at Philabundance food bank, part of their “Give Like a Centurion Week” (SOURCE: Life Science Cares) Life Science Cares: How Local Biotechs and [….]
Greater Philadelphia Q1 2023 News Recap – Ain’t No Stoppin’ Us Now While times are still rocky, in Q1 Greater Philly showed that it is still very much “on the [….]
The Philadelphia region, which includes Delaware and Southern New Jersey, is emerging as one of the top areas in the U.S. for the life sciences. So-called “Cellicon Valley” has numerous top academic institutions, and a range of biopharma companies working in drug discovery and development, as well as contract research organizations that manufacture and help deliver drugs. BioBuzz rounds up some of the leading companies in the region looking for top talent, with examples of a few of the jobs they’re currently hiring for.
BioBuzz rounds up some of the top Philadelphia life sciences companies looking to strengthen their teams for the coming year. The companies offer multiple job listings in different departments for candidates with a wide range of skills and experience levels.
This year, 2023, Century is focused on the execution of its vision by advancing multiple development candidates, primarily the Phase I ELiPSE-1 clinical trial of CNTY-101 in patients with relapsed or refractory CD19+ B-cell malignancies.
In the third quarter of 2021 alone, more than $400 million of private capital was invested in Maryland businesses. The money went to more than 34 different companies, according to data compiled by PitchBook. The deals brought the state to about $1.6 billion in funding for the first three-fourths of the year and placed Maryland on track to bring in about $2 billion worth of VC funding for the year. That was a significant jump over 2020, when Maryland saw about $1.26 billion in VC funding. For the industry at large in 2020, VC activity in biotechs grew by 45% to $36.6 billion.
Century Therapeutics Announces Presentation of Data at the 63rd American Society of Hematology Annual Meeting and Provides Pipeline Updates – In vivo data presented at ASH Annual Meeting demonstrated strong antitumor activity [….]
Robust Investment in Greater Philadelphia Region’s Cell and Gene Therapy Sector Continued in the First Quarter of 2021 PHILADELPHIA (April 8, 2021) – The robust venture capital funding the Greater [….]
